Can a targeted nerve block replace opioids for chemoport surgery?

NCT ID NCT07771712

NEW Completed Symptom relief Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This trial tests whether a combined nerve block can provide better pain relief than standard local anesthesia for cancer patients undergoing chemoport implantation. The study will compare the two approaches in 80 adults, measuring the need for extra pain medication during the procedure, as well as post-surgery pain and satisfaction. If successful, this technique could reduce opioid use and improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Combined pectoserratus plane and superficial cervical plexus block using bupivacaine
What this could lead to: If effective, this nerve block technique could offer cancer patients a more comfortable chemoport implantation with less pain and fewer opioids.
What could go wrong: This is a small, early-stage trial, and the block may not consistently outperform standard care. There are also risks like local anesthetic toxicity or nerve injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER PERIOPERATIVE ANALGESIA

Contacts and locations

Locations

MRCCC Siloam Hospitals Semanggi

Jakarta, DKI Jakarta, 12930, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.